Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase NA 1Phase 1 1

Status

Recruiting 7Not yet recruiting 5Completed 5Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 7

Conditions

Breast Neoplasms 529Neoplasms 475Carcinoma, Non-Small-Cell Lung 394Prostatic Neoplasms 308Colorectal Neoplasms 296Lung Neoplasms 259Neoplasm Metastasis 218Ovarian Neoplasms 200Leukemia, Myeloid, Acute 199Pancreatic Neoplasms 187Multiple Myeloma 175Squamous Cell Carcinoma of Head and Neck 134Recurrence 132Stomach Neoplasms 131Brain Neoplasms 126Carcinoma, Hepatocellular 125Melanoma 124Endometrial Neoplasms 122Glioblastoma 118Triple Negative Breast Neoplasms 111Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Hematologic Neoplasms 100Head and Neck Neoplasms 99Lymphoma 97Carcinoma, Renal Cell 97Urinary Bladder Neoplasms 93Sarcoma 90Glioma 88Lymphoma, Non-Hodgkin 82Rectal Neoplasms 81

Interventions

elacestrant 2AZD9833 2trastuzumab deruxtecan 1toripalimab 1ribociclib 1palbociclib 1exemestane 1disitamab vedotin 1abemaciclib 1Selective Estrogen Receptor Modulators 1RAD1901 1Letrozole 1Gonadotropin-Releasing Hormone 1Fulvestrant 1Everolimus 1Anastrozole 1AZD5305 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Recruiting × Advanced Breast Cancer × 90 days × Clear all
NCT06486883 2026-06-02

PONTIAC

MedSIR

Phase 2 Recruiting
200 enrolled
Breast

Advanced Breast Cancer

NCT07427394 2026-05-28

SERENA-1b

AstraZeneca

Phase 2 Recruiting
24 enrolled
Breast

Advanced Breast Cancer

NCT06380751 2026-05-15

EvoPAR-BR01

AstraZeneca

Phase 3 Recruiting
500 enrolled
Breast

Advanced Breast Cancer

NCT05831878 2026-05-13

RC48-ADC in HER2-low Advanced Breast Cancer

RenJi Hospital

Phase NA Recruiting
36 enrolled
Breast

Advanced Breast Cancer

NCT06638307 2026-05-12

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

Stemline Therapeutics, Inc.

Phase 1 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

NCT07540533 2026-04-20

2025-370

Henan Cancer Hospital

Phase 2 Recruiting
92 enrolled
Breast

Advanced Breast Cancer

NCT06382948 2026-04-03

ADELA

MedSIR

Phase 3 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡